ASPIRIN-DIPYRIDAM ER 25-200 MG

What it is

ASPIRIN-DIPYRIDAM ER 25-200 MG is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “aspirin and extended-release dipyridamole”, “asprin and extended-release dipyridamole”, “aspirin and dipyridamole” and “aspirin and extended - release dipyridamole”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg”.

FDA gives its dosage form as “capsule” and “capsule, extended release” and its route as oral.

FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, NorthStar Rx LLC and Micro Labs Limited.

FDA lists it under 2 Established Pharmacologic Classes: Nonsteroidal Anti-inflammatory Drug and Platelet Aggregation Inhibitor.

The NADAC file of 2026-10-14 prices it under 7 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $16.76 for 30 capsules (30 × $0.55859 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 capsules · NADAC explanation codes

The 7 labelers

Compared with its class

The middle of its 7 NDCs’ NADAC prices is $0.55859 per EA filed.

Of the 154 other products in FDA’s Nonsteroidal Anti-inflammatory Drug class priced per EA, 40 have a higher middle NADAC price and 114 a lower one. The one in the middle is INDOMETHACIN 25 MG CAPSULE, at $0.09341 per EA filed (eff. 2026-09-23).

Of the 35 other products in FDA’s Platelet Aggregation Inhibitor class priced per EA, 3 have a higher middle NADAC price and 32 a lower one. The one in the middle is SM ASPIRIN 81 MG CHEWABLE TAB, at $0.02571 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $48.47 for 30 capsules, at an average of $1.61551 per EA in 2024 (2024-01-01 to 2024-12-31) for “Aspirin-Dipyridamole ER” and “Aspirin/Dipyridamole”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 93,409 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

6 of the product’s 7 NDCs have this Medicare figure; the other 1 do not, and the interactive card says why for each.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.